Sanofi and GSK grab largest Warp Speed deal yet, se­cur­ing $2.1B for a vac­cine that might come next year

Sanofi and Glax­o­SmithK­line have be­come the lat­est mem­bers of Op­er­a­tion Warp Speed, land­ing a $2.1 bil­lion con­tract to scale up man­u­fac­tur­ing for a vac­cine that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER